Search results for "Acting"

showing 10 items of 338 documents

Evidence for a Smooth Onset of Deformation in the Neutron-Rich Kr Isotopes

2012

The neutron-rich nuclei Kr94,96 were studied via projectile Coulomb excitation at the REX-ISOLDE facility at CERN. Level energies of the first excited 2 + states and their absolute E2 transition strengths to the ground state are determined and discussed in the context of the E(21+) and B(E2;21+→01+) systematics of the krypton chain. Contrary to previously published results no sudden onset of deformation is observed. This experimental result is supported by a new proton-neutron interacting boson model calculation based on the constrained Hartree-Fock-Bogoliubov approach using the microscopic Gogny-D1M energy density functional. © 2012 American Physical Society.

Quantum phase transition[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]REX-ISOLDENuclear TheoryQUANTUM PHASE-TRANSITIONSGeneral Physics and Astronomychemistry.chemical_elementContext (language use)Coulomb excitationNuclear Structure01 natural sciencesREGIONNuclear physics0103 physical sciencesNuclear Physics - ExperimentNeutron010306 general physicsNuclear ExperimentDETECTORINTERACTING BOSONSPhysicsEXCITATIONSCOLLECTIVE NUCLEAR-STATESta114010308 nuclear & particles physicsKryptonFísicachemistryExcited stateSHELL-MODELInteracting boson modelAtomic physicsGround statePhysical Review Letters
researchProduct

Homogeneous actions on the random graph

2018

We show that any free product of two countable groups, one of them being infinite, admits a faithful and homogeneous action on the Random Graph. We also show that a large class of HNN extensions or free products, amalgamated over a finite group, admit such an action and we extend our results to groups acting on trees. Finally, we show the ubiquity of finitely generated free dense subgroups of the automorphism group of the Random Graph whose action on it have all orbits infinite.

Random graphFinite group20B22 (primary) 20E06 20E05 05C63 54E52 (secondary)Group Theory (math.GR)Homogeneous actions16. Peace & justicegroups acting on trees[MATH.MATH-GR]Mathematics [math]/Group Theory [math.GR]Action (physics)CombinatoricsMathematics::Group TheoryFree productHomogeneousBaire category theoremFOS: MathematicsDiscrete Mathematics and CombinatoricsCountable setBaire category theoremfree groupsGeometry and TopologyFinitely-generated abelian groupMathematics - Group TheoryMSC: 20B22 (primary); 20E06 20E05 05C63 54E52 (secondary)random graphMathematicsGroups, Geometry, and Dynamics
researchProduct

Dynamics and reactivity in Thermus aquaticus N6-adenine methyltransferase.

2014

M.TaqI is a DNA methyltransferase from Thermus aquaticus that catalyzes the transfer of a methyl group from S-adenosyl-l-methionine to the N6 position of an adenine, a process described only in prokaryotes. We have used full atomistic classical molecular dynamics simulations to explore the protein–SAM–DNA ternary complex where the target adenine is flipped out into the active site. Key protein–DNA interactions established by the target adenine in the active site are described in detail. The relaxed structure was used for a combined quantum mechanics/molecular mechanics exploration of the reaction mechanism using the string method. According to our free energy calculations the reaction takes…

Reaction mechanismSite-Specific DNA-Methyltransferase (Adenine-Specific)BioinformaticsStereochemistryProtein ConformationMolecular Dynamics SimulationBiochemistryCatalysisMolecular dynamicschemistry.chemical_compoundColloid and Surface ChemistryReaction rate constantAbstractingA-DNAThermusTernary complexThermus aquaticusbiologyActive siteGeneral ChemistryDNAbiology.organism_classificationchemistryFunctional groupsbiology.proteinAmino acidsNucleic Acid ConformationQuantum TheoryThermodynamicsMethyl groupJournal of the American Chemical Society
researchProduct

Scientific abstracts and plain language summaries in psychology: A comparison based on readability indices.

2020

Findings from psychological research are usually difficult to interpret for non-experts. Yet, non-experts resort to psychological findings to inform their decisions (e.g., whether to seek a psychotherapeutic treatment or not). Thus, the communication of psychological research to non-expert audiences has received increasing attention over the last years. Plain language summaries (PLS) are abstracts of peer-reviewed journal articles that aim to explain the rationale, methods, findings, and interpretation of a scientific study to non-expert audiences using non-technical language. Unlike media articles or other forms of accessible research summaries, PLS are usually written by the authors of th…

Research FacilitiesApplied psychologyInformation Storage and RetrievalSocial Sciences050109 social psychologyInformation Centers0302 clinical medicineMathematical and Statistical TechniquesReading (process)Science communicationPsychologyPlain languagemedia_commonLanguageGrammarMultidisciplinaryArchives05 social sciencesStatisticsQRSyllablesResearch AssessmentSystematic reviewPhysical SciencesMedicinePsychologyResearch ArticleSystematic ReviewsAbstracting and Indexingmedia_common.quotation_subjectPeer ReviewScienceMEDLINEResearch and Analysis MethodsPhonology03 medical and health sciences0501 psychology and cognitive sciencesStatistical MethodsScientific PublishingAnalysis of VariancePsychological researchCognitive PsychologyBiology and Life SciencesLinguisticsReadabilityReading comprehensionReadingCognitive Science030217 neurology & neurosurgeryMathematicsNeurosciencePLoS ONE
researchProduct

Quality assessment of randomized controlled trial abstracts on drug therapy of periodontal disease from the abstracts published in dental Science Cit…

2020

Background Randomized controlled trials (RCTs) provide the highest level of evidence and are likely to influence clinical decision-making. This study evaluated the reporting quality of RCT abstracts on drug therapy of periodontal disease and assessed the associated factors. Material and Methods The Pubmed database was searched for periodontal RCTs published in Science Citation Indexed (SCI) dental journals from 2010/01/01 to 2019/07/17. Information was extracted from the abstracts according to a modified Consolidated Standards of Reporting Trials (CONSORT) guideline checklist. The data was analyzed using descriptive statistical analysis and the statistical associations were examined using t…

Research designmedicine.medical_specialtyAbstracting and IndexingMEDLINElaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineHumansMedicinePeriodontologyGeneral DentistryPeriodontal DiseasesRandomized Controlled Trials as TopicIntention-to-treat analysisbusiness.industryResearchConsolidated Standards of Reporting Trials030206 dentistryGuideline:CIENCIAS MÉDICAS [UNESCO]ChecklistConfidence intervalChecklistOtorhinolaryngologyResearch DesignUNESCO::CIENCIAS MÉDICASSurgeryPeriodicals as Topicbusiness
researchProduct

RNAs That Behave Like Prions

2020

The term “prion” was originally coined to describe the proteinaceous infectious agents involved in mammalian neurological disorders. More recently, a prion has been defined as a nonchromosomal, protein-based genetic element that is capable of converting the copies of its own benign variant into the prion form, with the new phenotypic effects that can be transmitted through the cytoplasm. Some prions are toxic to the cell, are able to aggregate and/or form amyloid structures, and may be infectious in the wild, but none of those traits are seen as an integral property of all prions. We propose that the definition of prion should be expanded, to include the inducible transmissible entities und…

RiboswitchMolecular Biology and PhysiologyAmyloidProtein ConformationPrionsanimal diseaseslcsh:QR1-502viroidsPiwi-interacting RNApiRNABiologyribozymesMicrobiologylcsh:Microbiology03 medical and health sciencesMice0302 clinical medicineAnimalsHumansRibozymesprionsMolecular Biology030304 developmental biologyGenetics0303 health sciencesRibozymeRNAOpinion/HypothesisPhenotypeViroidsQR1-502nervous system diseasesCytoplasmbiology.proteinGenetic elementRNA030217 neurology & neurosurgerymSphere
researchProduct

Dual-targeting siRNAs.

2010

We have developed an algorithm for the prediction of dual-targeting short interfering RNAs (siRNAs) in which both strands are deliberately designed to separately target different mRNA transcripts with complete complementarity. An advantage of this approach versus the use of two separate duplexes is that only two strands, as opposed to four, are competing for entry into the RNA-induced silencing complex. We chose to design our dual-targeting siRNAs as Dicer substrate 25/27mer siRNAs, since design features resembling pre-microRNAs (miRNAs) can be introduced for Dicer processing. Seven different dual-targeting siRNAs targeting genes that are potential targets in cancer therapy have been develo…

STAT3 Transcription FactorSmall interfering RNATranscription GeneticTrans-acting siRNAGenes mycMethodComputational biologyKidneyPolymerase Chain ReactionCell LineSuppression GeneticRNA interferencemicroRNAGene silencingHumansRNA MessengerRNA Small InterferingMolecular BiologyGeneticsGene knockdownbiologyBase SequenceRNAProtein Biosynthesisbiology.proteinProto-Oncogene Proteins c-bcl-6AlgorithmsDicerRNA (New York, N.Y.)
researchProduct

Direct interaction of the Usher syndrome 1G protein SANS and myomegalin in the retina

2011

Contains fulltext : 96822.pdf (Publisher’s version ) (Closed access) The human Usher syndrome (USH) is the most frequent cause of combined hereditary deaf-blindness. USH is genetically heterogeneous with at least 11 chromosomal loci assigned to 3 clinical types, USH1-3. We have previously demonstrated that all USH1 and 2 proteins in the eye and the inner ear are organized into protein networks by scaffold proteins. This has contributed essentially to our current understanding of the function of USH proteins and explains why defects in proteins of different families cause very similar phenotypes. We have previously shown that the USH1G protein SANS (scaffold protein containing ankyrin repeat…

Scaffold proteinUsher syndromePhosphodiesterase 4D interacting protein (PDE4DIP)Muscle ProteinsPlasma protein bindingMice0302 clinical medicineYeastsChlorocebus aethiopsNuclear proteinCells CulturedGenetics0303 health scienceseducation.field_of_studyNuclear ProteinsCell biologyCOS CellssymbolsPhotoreceptor Cells VertebrateProtein BindingMicrotubule based transportNerve Tissue ProteinsBiologyModels BiologicalRetina03 medical and health sciencessymbols.namesakemedicineAnimalsHumanseducationMolecular BiologyAdaptor Proteins Signal Transducing030304 developmental biologyCell BiologyGlycostation disorders [IGMD 4]Golgi apparatusmedicine.diseaseMacaca mulattaMice Inbred C57BLCytoskeletal ProteinsPhotoreceptor cell functionMyomegalinGenetics and epigenetic pathways of disease Functional Neurogenomics [NCMLS 6]CattleAnkyrin repeatCiliary baseIntracellular transport030217 neurology & neurosurgerySensorineuronal degeneration
researchProduct

Preface

2014

Settore L-ART/05 - Discipline Dello SpettacoloDrammatica method acting
researchProduct

[Access to hepatitis C treatment: a lesson for the future.]

2018

L’immissione in commercio dei farmaci antivirali ad azione diretta (DAA) di nuova generazione per la terapia dell’infezione cronica da virus dell’epatite C ha rivoluzionato lo scenario precedente e ha messo a dura prova le istituzioni, a causa del prezzo elevato delle terapie. Un’analisi di quanto accaduto negli ultimi tre anni, specialmente in Italia, ci aiuta a comprendere come è stata gestita la contrattazione dei prezzi e soprattutto con quali criteri si è scelto, in una prima fase, di consentire un accesso ristretto in base al bisogno di cura dei pazienti. Ciò consente di mettere a fuoco alcuni temi importanti e di individuare le sfide che ci attendono nel prossimo futuro. The new gene…

Settore MED/02 - Storia Della MedicinaBioethics Hepatitis C Access policies Ethics HCV High price innovative drugs Access to treatment Direct Acting Antivirals Equity ScreeningItalyBioetica Epatite C Politiche di accesso Etica HCV Farmaci innovativi ad alto costo Accesso alle terapie Direct Acting Antivirals Equità ScreeningHumansHepatitis C ChronicAntiviral AgentsDrug CostsHealth Services AccessibilityRecenti progressi in medicina
researchProduct